M&A Deal Summary |
|
|---|---|
| Date | 2025-10-21 |
| Target | Digital Value |
| Sector | Information Technology |
| Buyer(s) | One Equity Partners |
| Deal Type | Going Private |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
One Equity Partners (OEP) is a private equity firm that targets buyout and growth capital investments in North America, Europe, and Asia. OEP prefers to be the lead investor and typically commits $30 to $150 million per transaction. Sectors of interest include industrial products/services, consumer, retail, chemicals, media, communications, and healthcare. One Equity Partners was formed in 2001 and spun out of JP Morgan Chase in 2015. One Equity Partners is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 138 of 138 |
| Sector: Information Technology M&A | 26 of 26 |
| Type: Going Private M&A Deals | 4 of 4 |
| Country: Italy M&A | 10 of 10 |
| Year: 2025 M&A | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-10-01 |
McNichols
Tampa, Florida, United States McNichols is a distributor of specialty metals and fiberglass products that comprise perforated and expanded metals, wire mesh, and designer metals, as well as bar grating, plank grating, fiberglass grating, and flooring products. McNichols was founded in 1952 and is based in Tampa, Florida. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-11-07 |
InfuCare Rx
Fairfield, New Jersey, United States InfuCare Rx is a provider of speciality infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. InfuCare Rx offers speciality infusion services with a focus on immunoglobulin therapy, chronic inflammatory therapy, acute and anti-infective therapy, bleeding disorders, and parenteral nutrition to help patients manage chronic conditions. InfuCare Rx was founded in 2014 and is based in Fairfield, New Jersey. |
Sell | - |
